Miv-cel Shows Durable Results in Stiff Person Syndrome and Myasthenia Gravis by Chad Birt| Published on: Oct 30, 2026

Miv-cel Shows Durable Results in Stiff Person Syndrome and Myasthenia Gravis by Chad Birt| Published on: Oct 30, 2026 Naji Gehchan, MD, MBA, Chief Medical and Development Officer at Kyverna Therapeutics, discusses one-year data showing sustained benefits of KYV-101 (mivocabtagene autoleucel ; Miv-cel) in stiff person syndrome (SPS), along with longer-term follow-up data in generalized myasthenia gravis (gMG). https://checkrare.com/miv-cel-shows-durable-results-in-stiff-person-syndrome-and-myasthenia-gravis/